recomWell Chlamydia pneumoniae
against Chlamydia pneumoniae in human serum or plasma
Mikrogen recomWell Chlamydia pneumoniae tests are qalitative and quantitative enzyme immunoassays, based on the antigens of the outer membrane complex of Chlamydia pneumoniae (COMC) they can be used for the detection of IgG, IgA and IgM antibodies of the pathogen. With the goal of distinguishing mild, clinically inconspicuous infections from clinically relevant infections, the test system was based on a cutoff of MIF ≥ 1:32. The test is characterized by a demonstrably excellent specificity compared to conventional ELISA tests.
Advantages
- High sensitivity due to the use of the highly immunogenic Chlamydia pneumoniae-specific membrane complex (COMC)
- High reliability due to good agreement with the microimmunofluorescence gold standard (MIF)
- Excellent specificity of the test due to minimal cross-reactivity with Chlamydia trachomatis infections in IgA and IgM detection, and no cross-reactivity with Mycoplasma IgM-positive sera in IgA and IgM detection
- Optimal support for clarification of immune status and helpful serodiagnostic supplement to clinical and radiological examination - based on separate detection of IgG, IgM and IgA antibodies
- Use of single strips possible
Safe and reliable
Fully automatic processing, software-based evaluation and connection to the laboratory information system possible
Flexible and compatible
Combination of all Mikrogen ELISA possible - uniform processing and interchangeable reagents
High Standard
CE mark: The recomWell Chlamydia pneumoniae test meet the high standard of the EC Directive 98/79/EC for in vitro diagnostic medical devices.